VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL
Product details
Registration number: SIN15950P
Classification: Prescription Only
Active ingredients: Remdesivir
Strength: 100mg
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
ATC code: J05AB16
HSA approval date: 10 June 2020
Manufacturer(s):
- Jubilant HollisterStier, LLC
- Patheon Manufacturing Services LLC
- Hikma Farmaceutica (Portugal) S.A.
- Hospira, Inc.
- Patheon Italia S.p.A.
- Valdepharm
- Xellia Pharmaceuticals USA LLC
Manufacturing country/countries: UNITED STATES; ITALY; FRANCE; PORTUGAL
What are the HSA registration number and classification for VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15950P
Classification: Prescription Only
What active ingredients and strength are recorded for VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Remdesivir
Strength: 100mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Jubilant HollisterStier, LLC
- Patheon Manufacturing Services LLC
- Hikma Farmaceutica (Portugal) S.A.
- Hospira, Inc.
- Patheon Italia S.p.A.
- Valdepharm
- Xellia Pharmaceuticals USA LLC
Manufacturing country/countries: UNITED STATES; ITALY; FRANCE; PORTUGAL
Where can I look up VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15950P or the exact product name VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL. The general register link does not preselect this product.
What are the source dates for this VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15950P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)